News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Noah Christian, MD

Advertisement

Articles by Noah Christian, MD

RSV Prophylaxis: Palivizumab, Nirsevimab, and More

By Noah Christian, MD,Joseph M. Collaco, MD, PhD
May 9th 2025

Current prevention strategies include two injectables for infants and young children, namely palivizumab and nirsevimab.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contagion Live

    1

    Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance

    2

    Cefiderocol is Noninferior, But not "Game-Changer," for Gram-negative Bloodstream Infections

    3

    Misdiagnosis Common in Skin Infections Due to Overlapping Noninfectious Conditions

    4

    As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link

    5

    Emerging Diagnostic Tools and Mycobacterial Challenges in Skin and Soft Tissue Infections

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Do Not Sell My Information
    • Privacy
    • Terms & Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us